| scholarly article | Q13442814 |
| P50 | author | Pierre De Meyts | Q18209260 |
| P2093 | author name string | Rasmus Jorgensen | |
| Sarah Norklit Roed | |||
| Anne Orgaard | |||
| P2860 | cites work | Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1 | Q24314090 |
| Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides | Q24324153 | ||
| Molecular tinkering of G protein-coupled receptors: an evolutionary success | Q24534016 | ||
| Family-B G-protein-coupled receptors | Q24542556 | ||
| Molecular cloning and expression of a cDNA encoding the secretin receptor | Q24561434 | ||
| G-protein-coupled receptor heterodimerization modulates receptor function | Q24603239 | ||
| Allostery at G Protein-Coupled Receptor Homo- and Heteromers: Uncharted Pharmacological Landscapes | Q24633877 | ||
| Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization | Q24653438 | ||
| Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor | Q27627995 | ||
| Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor | Q27647464 | ||
| Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain | Q27649890 | ||
| Molecular recognition of parathyroid hormone by its G protein-coupled receptor | Q27650193 | ||
| Dimeric Arrangement of the Parathyroid Hormone Receptor and a Structural Mechanism for Ligand-induced Dissociation | Q27659967 | ||
| Transmembrane segment IV contributes a functionally important interface for oligomerization of the Class II G protein-coupled secretin receptor | Q51795077 | ||
| Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors | Q51799487 | ||
| Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers | Q51810340 | ||
| Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers | Q51822453 | ||
| Overview of Receptor Allosterism | Q60299786 | ||
| Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors | Q81391458 | ||
| Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1 | Q81819667 | ||
| A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding | Q82309394 | ||
| Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism | Q27664362 | ||
| Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function | Q27919659 | ||
| Novel receptor partners and function of receptor activity-modifying proteins | Q28215813 | ||
| Secretin and vasoactive intestinal peptide receptors: Members of a unique family of G protein–coupled receptors | Q28260872 | ||
| Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor | Q28296331 | ||
| Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function | Q28364090 | ||
| The oligomeric state sets GABA(B) receptor signalling efficacy | Q28570219 | ||
| The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints | Q29547321 | ||
| Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery | Q33890786 | ||
| β-Adrenergic receptors: Evidence for negative cooperativity | Q33948427 | ||
| Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization | Q34079450 | ||
| An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects | Q34164718 | ||
| Oligomerisation of G-protein-coupled receptors. | Q34188957 | ||
| Insulin interactions with its receptors: experimental evidence for negative cooperativity. | Q34207711 | ||
| Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors | Q34263173 | ||
| GCRDb: a G-protein-coupled receptor database | Q34333530 | ||
| Fluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling. | Q34345068 | ||
| The structural basis of negative cooperativity: receptors and enzymes | Q34413228 | ||
| Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). | Q34496062 | ||
| Application of G protein-coupled receptor-heteromer identification technology to monitor β-arrestin recruitment to G protein-coupled receptor heteromers | Q34555919 | ||
| Cooperative properties of hormone receptors in cell membranes | Q34675962 | ||
| The insulin receptor: a prototype for dimeric, allosteric membrane receptors? | Q34798186 | ||
| G-protein-coupled receptor oligomerization and its potential for drug discovery | Q34932201 | ||
| G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding | Q35008902 | ||
| Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) | Q35120622 | ||
| Corticotropin-releasing factor signaling and visceral response to stress | Q35203621 | ||
| Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2) | Q35546451 | ||
| Roles of G-protein-coupled receptor dimerization | Q35622424 | ||
| A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein | Q35778121 | ||
| Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors | Q36088758 | ||
| Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs? | Q36153231 | ||
| Methods to monitor the quaternary structure of G protein-coupled receptors | Q36162447 | ||
| Vasoactive intestinal peptide family as a therapeutic target for Parkinson's disease. | Q36268291 | ||
| Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. | Q36422842 | ||
| Insights into the structural basis of endogenous agonist activation of family B G protein-coupled receptors | Q36710162 | ||
| Secretin receptor oligomers form intracellularly during maturation through receptor core domains | Q36826025 | ||
| Computational studies of Family A and Family B GPCRs | Q36883937 | ||
| Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors | Q36945112 | ||
| Glucagon receptors | Q37091792 | ||
| Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor | Q37177027 | ||
| The incretin system and its role in type 2 diabetes mellitus | Q37266863 | ||
| Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes | Q37360316 | ||
| The apparent cooperativity of some GPCRs does not necessarily imply dimerization. | Q37408661 | ||
| Incretin-based therapy of type 2 diabetes mellitus | Q37411508 | ||
| Exploration of the endogenous agonist mechanism for activation of secretin and VPAC1 receptors using synthetic glycosylated peptides | Q37417464 | ||
| Pattern of intra-family hetero-oligomerization involving the G-protein-coupled secretin receptor | Q37430299 | ||
| CRF receptors as a potential target in the development of novel pharmacotherapies for depression | Q37481959 | ||
| NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor | Q37511744 | ||
| Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization | Q37629365 | ||
| Back to the future: revisiting parathyroid hormone and calcitonin control of bone remodeling | Q37706351 | ||
| PTH analogues and osteoporotic fractures | Q37772506 | ||
| The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease | Q37840099 | ||
| Glucagon antagonism as a potential therapeutic target in type 2 diabetes | Q37880234 | ||
| Regulation of glucagon secretion by incretins | Q37913515 | ||
| The role of dysregulated glucagon secretion in type 2 diabetes | Q37913523 | ||
| Oligomerization of G protein-coupled receptors: biochemical and biophysical methods. | Q37921841 | ||
| Lateral Allosterism in the Glucagon Receptor Family: Glucagon-Like Peptide 1 Induces G-Protein-Coupled Receptor Heteromer Formation | Q39438615 | ||
| Monitoring protein-protein interactions in living cells by bioluminescence resonance energy transfer (BRET). | Q39989615 | ||
| Cooperative binding of insulin-like Peptide 3 to a dimeric relaxin family peptide receptor 2. | Q40038592 | ||
| Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET. | Q40132758 | ||
| Opsin oligomerization in a heterologous cell system | Q40205844 | ||
| Possible endogenous agonist mechanism for the activation of secretin family G protein-coupled receptors | Q40306029 | ||
| Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity | Q40423659 | ||
| Rational design, synthesis, and biological evaluation of novel growth hormone releasing factor analogues | Q40614410 | ||
| A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. | Q41186190 | ||
| Functional importance of a structurally distinct homodimeric complex of the family B G protein-coupled secretin receptor | Q41883095 | ||
| Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer? | Q42806160 | ||
| Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma | Q44138569 | ||
| Negative cooperativity among beta-adrenergic receptors in frog erythrocyte membranes | Q44182279 | ||
| The alternatively spliced deltae13 transcript of the rabbit calcitonin receptor dimerizes with the C1a isoform and inhibits its surface expression | Q44397881 | ||
| Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness | Q46841539 | ||
| Dimerization of corticotropin-releasing factor receptor type 1 is not coupled to ligand binding | Q46880025 | ||
| Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling | Q46977928 | ||
| P921 | main subject | G protein-coupled receptor | Q38173 |
| P304 | page(s) | 62 | |
| P577 | publication date | 2012-05-07 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Receptor oligomerization in family B1 of G-protein-coupled receptors: focus on BRET investigations and the link between GPCR oligomerization and binding cooperativity | |
| P478 | volume | 3 |
| Q27025870 | Action and therapeutic potential of oxyntomodulin |
| Q37501628 | Comment on "The Use of BRET to Study Receptor-Protein Interactions" |
| Q41902981 | Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking |
| Q38220597 | Moonlighting adenosine deaminase: a target protein for drug development |
| Q34781241 | PACAP induces the dimerization of PAC1 on the nucleus associated with the cAMP increase in the nucleus |
| Q42567375 | Receptor oligomerization: from early evidence to current understanding in class B GPCRs. |
| Q64226623 | Receptor-Receptor Interactions as a Widespread Phenomenon: Novel Targets for Drug Development? |
| Q34532319 | The N-Terminal HSDCIF Motif Is Required for Cell Surface Trafficking and Dimerization of Family B G Protein Coupled Receptor PAC1 |
| Q28082755 | Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors |
| Q27001704 | Unraveling oxyntomodulin, GLP1's enigmatic brother |
Search more.